secwatch.observer — SEC 8-K summary
======================================

Issuer:     Royalty Pharma plc (RPRX)
CIK:        0001802768
Form:       8-K
Filed at:   2025-09-16T23:59:59+00:00
Accession:  0001193125-25-204983
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Royalty Pharma prices $2B senior notes in three tranches: 2031, 2035, 2055
--------------------------------------------------------------------------

- $600M 4.450% notes due 2031, $900M 5.200% notes due 2035, $500M 5.950% notes due 2055.
- Notes are senior unsecured and guaranteed by Royalty Pharma Holdings Ltd and RP Manager LLC.
- Issuance closed September 16, 2025; interest payments begin March 25, 2026.
- Underwriters include BofA, Goldman Sachs, J.P. Morgan, Morgan Stanley, and TD Securities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802768/000119312525204983/0001193125-25-204983-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802768/000119312525204983/d58607d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-204983

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer